ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,393.80
0.85%
S&P ASX All Technology
3,840.60
-1.02%
Brent Oil
74.65
0.00%
US Dollar vs AUD
1.53846
0.06%
Bitcoin
98,785.87
-0.25%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Aridis Pharmaceuticals Inc (CE) (ARDS)

  7. Aridis Pharmaceuticals Inc (CE) (ARDS) News

ARDS

Aridis Pharmaceuticals (CE) (ARDS)

Aridis Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ARDS
DateTimeSourceHeadlineSymbolCompany
19/12/202301:43Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
19/12/202301:40Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
16/12/202309:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
07/11/202308:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARDSAridis Pharmaceuticals Inc (CE)
20/09/202306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
20/09/202306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
20/09/202306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
20/09/202306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
10/08/202306:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARDSAridis Pharmaceuticals Inc (CE)
27/07/202304:56Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:ARDSAridis Pharmaceuticals Inc (CE)
29/01/202009:19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARDSAridis Pharmaceuticals Inc (CE)
14/01/202008:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARDSAridis Pharmaceuticals Inc (CE)
14/01/202007:48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARDSAridis Pharmaceuticals Inc (CE)
03/01/202008:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARDSAridis Pharmaceuticals Inc (CE)
31/12/201906:51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARDSAridis Pharmaceuticals Inc (CE)
14/11/201908:33Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARDSAridis Pharmaceuticals Inc (CE)
14/11/201908:27Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARDSAridis Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ARDS

Your Recent History

COIN
SOLUSD
Solana
ASX
RIO
Rio Tinto
NYSE
DIS
Walt Disney
ASX
XFL
S&P ASX 50
NASDAQ
AMZN
Amazon.com
ASX
XMM
S&P ASX 300 Metals and M...
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
BHP
BHP
ASX
WPL
Woodside Petroleum
ASX
AMP
AMP
NYSE
VZ
Verizon Communications
NYSE
MCD
McDonalds
FX
AUDJPY
AUD vs Yen
ASX
WDC
Westfield
FX
GBPAUD
Sterling vs AUD
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved